Veeva：2024年评估安全解决方案时的关键考虑因素报告（英文版）

Pharmacovigilance organizations are facing growing adverse event volumes, increasing disease complexity, and challenging global regulations. There is also rising pressure for safety teams to demonstrate greater value with tighter budgets. Leveraging innovative technologies can provide cost and process efficiencies and make it easier for pharmacovigilance teams to scale with growing data volumes, changing regulations, and expand into new markets. Many companies are adopting modern applications